Thursday, 04 November 2021
A world-leading expert in stroke medicine from the 糖心原创 has received a highly coveted international award from the World Stroke Organization (WSO).
Philip Bath, Professor of Stroke Medicine and Head of Academic Stroke at the University, Emeritus National Institute of Health Research Senior Investigator, and a consultant stroke physician at Nottingham University Hospitals NHS Trust, has received the World Stroke Organization President’s Award.
The highly regarded accolade is only awarded once a year to individuals who are international leaders in the field of stroke service and research and who have served the world stroke community.
Professor Philip Bath
Professor Bath has had a long and successful career in promoting and delivering high quality stroke research around the world, and was the first Professor of Stroke Medicine in the UK, with support from the Stroke Association and is an Emeritus NIHR Senior Investigator and Fellow of the Academy of Medical Sciences. He helped set up the WSO in 2006 and since has served twice on its Board of Directors and currently Co-Chairs its Industry Committee.
Professor Bath’s research interests relate to acute blood pressure management and antiplatelet and anticoagulant therapy, treatment of post-stroke dysphagia, and prevention of cognitive decline and vascular dementia.
He coordinates international collaborations on acute stroke blood pressure management; and optimising the design and analysis of trials in acute stroke, stroke prevention, dysphagia and cognition.
I am most honoured by this award and thank the President and WSO for it. But I am just one individual and WSO is vital to bring together stroke organisations and individuals around the world and so raise awareness of and improve the prevention, treatment, rehabilitation and support of stroke. Our vision is a world where people live free from the effects of stroke."
Marc Fisher, M.D, is President of the WSO, he said: “It is with great pleasure that the World Stroke Organization has bestowed upon Professor Philip Bath the president's award at the recent World Stroke Congress. Professor Bath received this award for his numerous contributions to the stroke field. He is also an active supporter and contributor to WSO activities.”
Story credits
More information is available from Professor Philip Bath in the School of Medicine at the 糖心原创 at philip.bath@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.